We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Public Assessment Report (PAR) discussing new risk minimisation measures which are being put into place for certain over-the-counter (OTC) stimulant laxatives.
Methylamphetamine is a member of a broad class of psycho-stimulant compounds called amphetamines.
Advice on ingredients in nicotine-containing liquids in electronic cigarettes and refill containers.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
The Home Secretary has accepted the ACMD’s recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred…
Fifteen new synthetic opioids and 5 other drugs will be banned as Class A drugs as the government continues to act to prevent drug deaths.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
FCDO travel advice for Colombia. Includes safety and security, insurance, entry requirements and legal differences.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
People who take stimulant laxatives for constipation are being advised that these will now be sold in smaller packs, with on-pack warnings.
Government response to the ACMD review of the evidence on the use and harms of diphenidine.
We have introduced pack size restrictions, revised recommended ages for use, and new safety warnings for over-the-counter stimulant laxatives (orally and rectally administered) following a national safety review. Advise patients that dietary and lifestyle measures should be used first-line for...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.